Primary information |
---|
sequence ID | Seq_2164 |
Peptide sequence | FHNQEENVRF |
CancerPDF_ID | CancerPDF_ID13440, CancerPDF_ID13871, CancerPDF_ID13919, |
PMID | 20974924,20974924,20974924 |
Protein Name | "HLA class II histocompatibility antigen, DRB1-3 chain","HLA class II histocompatibility antigen, DRB1-3 chain","HLA class II histocompatibility antigen, DRB1-3 chain" |
UniprotKB Entry Name | 2B13_HUMAN,2B13_HUMAN,2B13_HUMAN |
Fluid | Plasma,Plasma,Plasma |
M/Z | 1319.613,1319.613,1319.613 |
Charge | 3,2,3 |
Mass (in Da) | NA,NA,NA |
fdr | NA,NA,NA |
Profiling Technique | LC-MS,LC-MS,LC-MS |
Peptide Identification technique | LC-MS/MS,LC-MS/MS,LC-MS/MS |
Quantification Technique | NA,NA,NA |
Labelled/Label Free | Label Free,Label Free,Label Free |
FDR | NA,NA,NA |
CancerPDF_ID | CancerPDF_ID13440, CancerPDF_ID13871, CancerPDF_ID13919, |
p-Value | NA,NA,NA |
Software | MASCOT and SEQUEST,MASCOT and SEQUEST,MASCOT and SEQUEST |
Length | NA,NA,NA |
Cancer Type | "Multiple myeloma patients, Acute myeloid leukemia","Multiple myeloma patients, Acute myeloid leukemia","Multiple myeloma patients, Acute myeloid leukemia" |
Database | Uniprot database,Uniprot database,Uniprot database |
Modification | NA,NA,NA |
Number of Patients | NA,NA,NA |
Regulation | NA,NA,NA |
Validation | NA,NA,NA |
Sensitivity | NA,NA,NA |
Specificity | NA,NA,NA |
Accuracy | NA,NA,NA |
Peptide Atlas | NA |
IEDB | |